SMTL ID : 4zy5.1 (1 other biounit)

Crystal Structure of p21-activated kinase 1 in complex with an inhibitor compound 17

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.35 Å

Oligo State

monomer

Ligands

1 x 4T5: N~2~-[(trans-4-aminocyclohexyl)methyl]-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine(Non-covalent)

4T5.1: 12 residues within 4Å: Chain A: I.29, V.37, A.50, M.97, E.98, Y.99, L.100, D.146, N.147, L.149, T.159 Ligands: SO4.3 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:V.37, A:A.50, A:L.149 Hydrogen bonds: A:L.100, A:L.100, A:D.146

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 4 residues within 4Å: Chain A: R.141, R.174, T.176, V.178 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:T.176, A:T.176 Salt bridges: A:R.141, A:R.174 SO4.3: 3 residues within 4Å: Chain A: K.144, D.160 Ligands: 4T5.1 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:K.144

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Crawford, J.J. et al., Structure-Guided Design of Group I Selective p21-Activated Kinase Inhibitors. J.Med.Chem. (2015)

Release Date

2015-07-01

Peptides

Serine/threonine-protein kinase PAK 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase PAK 1

Related Entries With Identical Sequence